The MCT1 expression influences drug absorptionand bioavailability and is associatedwith cancer metastasis. MCT1 is a highlyrelevant target for cancer treatment, and several drugs, includingthe MCT1 inhibitor AZD3965 (Figure ), are currently under clinical evaluation. This evidence concerns the gene SLC16A1 and cancer.